Page 48 - Pharma Sector

Centre working on policy to encourage research in pharma sector: Mandaviya

The central government is formulating a policy to encourage research in pharmaceutical sector for patented drugs, he said

Zydus gets orphan drug designation from USFDA for antimalarial compound

The orphan drug designation provides eligibility for certain development incentives

Sun Pharma Advanced Research Co signs licensing pact with Biomodifying

Biomodifying will also receive a percentage of payments received for sublicenses of the licensed IP

Without innovation Indian pharma cannot touch $130 bn by 2030: Industry

Sun Pharma says it eyes $1.5 bn from innovative products in 3-4 years

AIMIL Pharma launches ayurveda-based beauty product

The product -- Ayouthveda -- has been prepared by adding time-tested herbs

CCI releases key findings on market study of India's pharma sector

Necessary regulations needed to safeguard patient privacy, protect sensitive personal medical data, says CCI report

Sluggish exports may cap pharma YoY revenue growth in FY22, says Crisil

Revenue growth of India's pharmaceutical sector is expected to "moderate" to 9 per cent in FY22, as compared with a healthy rise of 12.5 per cent during the previous fiscal, Crisil said

PM to inaugurate first global innovation summit of pharma sector on Nov 18

Modi will inaugurate the First Global Innovation Summit of the Pharmaceuticals sector on November 18, 2021 at 4 PM via video conferencing, said a press release from the Prime Minister Office

Ipca Labs second quarter net profit declines 6% to Rs 250 crore

The board declared an interim dividend of Rs 8 per share

Suven Pharma second quarter net profit up 31% at Rs 97 crore

The Hyderabad-based company primarily operates in the contract development and manufacturing operations (CDMO) segment

Sun Pharma second quarter net profit rises 13% to Rs 2,047 crore

The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal

Pharma funds lag sectoral peers despite Covid tailwind as US market weighs

In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns

Ajanta Pharma second quarter profit rises 15% to Rs 196 crore

Shares of the company were trading 1.17 per cent down at Rs 2,102.80 apiece on the BSE

Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr

Revenue growth was primarily driven by good performance of its research services and biosimilars business segments

New-age pharmacy start-ups tap 'kirana' networks, eye US market

New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland

Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India

Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the 'Big Three', control over 90 per cent of the global insulin market

N Govindarajan steps down as Aurobindo Pharma managing director

Govindarajan has decided to step down due to "personal reasons", Aurobindo Pharma said in a regulatory filing

RPG Life Sciences hits record high, zooms 51% so far in September

The domestic formulations business of the company will continue to focus on building chronic therapies, expanding specialty portfolio and life cycle management of current legacy products

Vivek Chaand Sehgal resigns as director from Sun Pharmaceutical board

Drug firm Sun Pharmaceutical Industries on Friday said Vivek Chaand Sehgal has resigned as an independent director of the company with effect from September 1.

Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs

Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray